- ·The complete investor list: 13 names
- ·Watch neurocare: the Monday email on marks, rounds and moves
neurocare funding history
No funding rounds for neurocare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
neurocare valuation
neurocare's last known valuation is $75.8 million, from Jan 2024. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How neurocare's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For neurocare, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about neurocare
- What is neurocare worth?
- neurocare's last known valuation is $75.8M.
- How much has neurocare raised?
- neurocare has raised $20.0M in total funding across its recorded rounds.